| BOSTON SCIENTIFIC DL-,01 |
| USA |
| Gesundheit |
| US1011371077 / 884113 |
| BSX (Frankfurt) / BSX (NYSE) |
| FRA:BSX, ETR:BSX, BSX:GR, NYSE:BSX |
| S&P500 |
| http://www.bostonscientif.. |
|
Boston Scientific Corporation develops, manufactures, and markets a broad portfolio of medical devices designed for minimally invasive procedures worldwide. The company specializes in innovative technologies that address critical health needs across ..
>Volltext.. |
| 77217.55 Mio. EUR |
| 85907.51 Mio. EUR |
| 17101.84 Mio. EUR |
| 4633.47 Mio. EUR |
| 2468.8 Mio. EUR |
| 1.67 EUR |
| 10198.92 Mio. EUR |
| 1742.13 Mio. EUR |
| 3862.5 Mio. EUR |
| 0.38 |
| 5.66% |
| 37.85% |
| - |
| - |
| - |
| - |
| BOSTON SCIENTIFIC |
| 22.04.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|